Research
Search
Close
QIU Zhongling
- Chief Physician, Graduate Supervisor
- Department: Nuclear Medicine
- Research Area: Imaging and Nuclear Medicine (Nuclear Medicine)
- Research Interests: 131I treatment for differentiated thyroid cancer
- Contact: qiuzhongling123@163.com
- MD from Shanghai Jiao Tong University School of Medicine, 2000
- zhang GQ, Xi C, Shen CT, Song HJ, Luo QY, Qiu ZL.Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells. Endocr Relat Cancer. 2023 Jul 25;30(9):e230130；
- Xi C, Zhang Q, Song HJ, Shen CT, Zhang GQ, Sun JW, Qiu ZL, Luo QY.Pregnancy Does not Affect the Prognoses of Differentiated Thyroid Cancer Patients With Lung Metastases. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3185-e3197；
- Zhang GQ, Jiao Q, Shen CT, Song HJ, Zhang HZ, Qiu ZL, Luo QY.Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. Cancer Sci. 2021 Mar;112(3):997-1010.
- Shen CT, Qiu ZL, Song HJ, Wei WJ, Luo QY.J Exp Clin Cancer Res. 2016 Jun 24;35(1):101. Qiu ZL, Shen CT, Luo QY. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy. Thyroid. 2015 Feb;25(2):229-37.
- Qiu ZL, Song HJ, Xu YH, Luo QY.Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab. 2011 Oct;96(10):3078-86
- Weng HY, Yan T, Qiu WW, Xi C, Hou LY, Yang ZL, Qiu ZL.Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases. Endocrine. 2022 Feb;75(2):495-507. doi: 10.1007/s12020-021-02906-8.
- Deng XZ, Shi YF, Shen CT, Song HJ, Wang J, Fan YB, Luo QY, Qiu ZL.Clinical characteristics and long-term outcomes for parapharyngeal metastases of well-differentiated thyroid cancer during 131 I therapy and follow-up.Clin Endocrinol (Oxf). 2023 Jul;99(1):92-102.
- Wei WJ, Sun ZK, Shen CT, Song HJ, Zhang XY, Qiu ZL, Luo QY.Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer.Theranostics. 2017 Feb 23;7(4):987-1001.
- Qiu ZL, Shen CT, Sun ZK, Song HJ, Zhang GQ, Luo QY.Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators. Front Endocrinol (Lausanne). 2020 Jan 10;10:903.
- Qiu ZL, Xu YH, Song HJ, Luo QY.Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT.Head Neck. 2011 Feb;33(2):171-7.
